未来，圣湘生物将通过AI与生命健康深度融合，加速推进体外诊断行业数字化变革，为构建智慧医疗新生态提供创新样本。同时公司将以数据为基础、算力为支撑，围绕诊疗一体化、个性化方案储备资源和能力，规范开展数智化及AI工作，构建医疗行业新质生产力。

Shares retreated Friday in Europe and Asia, with benchmarks in Japan, Hong Kong and South Korea tumbling more than 2% as U.S.

It is worth noting that Broadcom has clawed back a nice chunk of those losses, though the stock is still down 6% in 2025. However, the chip designer's upcoming fiscal 2025 first-quarter results, ...

The software firm beat earnings and gave strong guidance that played up new AI tools for customers. It's outlook for product ...

GPTY and AIPI seek similar objectives of providing current income and capital appreciation from an AI-focused tech portfolio ...

Without question, investors are turning their attention to AI chip king Nvidia and the company's release of its fiscal year ...

Investors are anxiously waiting for Nvidia’s (NVDA) fourth-quarter earnings report, which may provide a much-needed boost to ...

Baidu could see further gains thanks to its advancements in AI—including Ernie Bot and self-driving technology—and by being ...

With Nvidia shares under pressure this year, they're essentially back to where they were six months ago. And Nvidia isn't alone. Various other artificial-intelligence stocks have seen their momentum ...

We recently published a list of Top 10 Buzzing AI Stocks to Watch Now. In this article, we are going to take a look at where ...

Stocks slid Thursday, weighed down by chipmaker Nvidia, which dragged semiconductor and other AI stocks lower.

Results from Salesforce Inc. this week pose a key test for the stock and for what many believe is the next big thing in ...